| Plasma ghrelin concentrations in type 1 diabetic patients with autoimmune atrophic gastritis. | |
| | |
MedLine Citation:
|
PMID: 18057384 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: Type 1 diabetes mellitus patients (DM1) show increased prevalence of pernicious anaemia, the histological substrate of which is type A chronic atrophic gastritis (CAG) in the stomach corpus, the main source of ghrelin. We aimed to compare plasma ghrelin concentrations in DM1 patients with type A CAG (DM1-CAG), DM1 patients without type A CAG and healthy controls and in DM1-CAG group, to ascertain a possible relationship between ghrelin and biochemical markers of gastric mucosa atrophy and/or neuroendocrine (NE) cell hyperplasia and histological gastric biopsy findings. DESIGN AND METHODS: Fifteen DM1-CAG patients were matched for age, sex and body mass index with 15 DM1 patients without type A CAG and 15 controls. Pepsinogen I, pepsinogen II, gastrin, parietal cell antibodies, chromogranin A (CgA) and ghrelin were determined in all subjects. In DM1-CAG patients, immunohistochemical analysis of gastric biopsies using antibodies to CgA and ghrelin was performed. RESULTS: Ghrelin concentrations differed among groups; however, paired comparisons between groups were not significant. In DM1-CAG, no correlation was found between ghrelin and gastric body atrophy markers, pepsinogen I and the pepsinogen I/II ratio. Immunohistochemical studies of DMI-CAG patients showed CgA staining in 12 and ghrelin staining in 6, which was confined to the foci of NE cell hyperplasia. Those patients who stained positive for ghrelin had higher ghrelin concentrations when compared with the negative patients. CONCLUSIONS: Ghrelin concentrations are not decreased in DM1-CAG patients; thus, our data suggest that ghrelin is not a good marker of gastric mucosa atrophy in these patients, given the possible ghrelin synthesis in hyperplastic gastric endocrine/enterochromaffin-like cells. |
| | |
Authors:
|
Núria Alonso; María Luisa Granada; Isabel Salinas; Jorge Luis Reverter; Lilliam Flores; Isabel Ojanguren; Eva María Martínez-Cáceres; Anna Sanmartí |
Related Documents
:
|
11743254 - Nutritional problems in end-stage liver disease: contribution of impaired gastric empty... 15946444 - Topical benzocaine (hurricaine) induced methemoglobinemia during endoscopic procedures ... 21719424 - Vitamin d levels in chinese patients with systemic lupus erythematosus: relationship wi... 9849494 - Effects of ondansetron on gastrointestinal symptoms in carcinoid syndrome. 17505034 - Cd4-regulatory cells in copd patients. 23112564 - Severe acute cholangitis after endoscopic sphincterotomy induced by barium examination:... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: European journal of endocrinology / European Federation of Endocrine Societies Volume: 157 ISSN: 1479-683X ISO Abbreviation: Eur. J. Endocrinol. Publication Date: 2007 Dec |
Date Detail:
|
Created Date: 2007-12-06 Completed Date: 2007-12-20 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9423848 Medline TA: Eur J Endocrinol Country: England |
Other Details:
|
Languages: eng Pagination: 763-9 Citation Subset: IM |
Affiliation:
|
Department of Endocrinology and Nutrition, Hospital Universitari Germans Trias i Pujol, Ctra Canyet s/n, Badalona 08916, Barcelona, Spain. nalonso.germanstrias@gencat.net |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Autoimmune Diseases / blood*, pathology Diabetes Mellitus, Type 1 / blood*, complications Female Gastric Mucosa / pathology Gastritis, Atrophic / blood*, etiology, pathology Ghrelin / blood* Helicobacter Infections / blood Helicobacter pylori Humans Hyperplasia / pathology Male Middle Aged |
| Chemical | |
Reg. No./Substance:
|
0/Ghrelin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Analysis of extended human leukocyte antigen haplotype association with Addison's disease in three p...
Next Document: Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results.